Anthracycline is often used for treatment of hematologic malignancies and solid tumors, and the damage it causes to the heart muscle has long been known; therefore, the cardiac toxicity, one of the treatment-related co-morbidities, has become an issue for cancer survivors. Cardiotoxicity has been defined using various classifications. In this paper we report the case of a man affected by follicular non-Hodgkin’s lymphoma, which was first diagnosed in 2006 and had a second recurrence in 2012 with a mediastinal mass: the patient was subjected to a new cycle of chemotherapy with anthracycline, the follow-up exam showed a significant reduction of the mass, but the clinical condition worsened and the ejection fraction of the left ventricle had a progressive reduction, as seen in the cardiac-MRI test. Then, it was decided to discontinue therapy with anthracycline, resulting in a clear recovery of systolic function of the left ventricle, as seen in the following echocardiogram.

Anthracycline cardiotoxicity in non-Hodgkin’s lymphoma mediastinal mass: A case report

Chiodi, Elisabetta;NATALI, Marcello;FERRANTE, Zairo;MALTA, Bruna;MONTALTO, Clorinda;GIGANTI, Melchiore;BENEA, GIORGIO
2015

Abstract

Anthracycline is often used for treatment of hematologic malignancies and solid tumors, and the damage it causes to the heart muscle has long been known; therefore, the cardiac toxicity, one of the treatment-related co-morbidities, has become an issue for cancer survivors. Cardiotoxicity has been defined using various classifications. In this paper we report the case of a man affected by follicular non-Hodgkin’s lymphoma, which was first diagnosed in 2006 and had a second recurrence in 2012 with a mediastinal mass: the patient was subjected to a new cycle of chemotherapy with anthracycline, the follow-up exam showed a significant reduction of the mass, but the clinical condition worsened and the ejection fraction of the left ventricle had a progressive reduction, as seen in the cardiac-MRI test. Then, it was decided to discontinue therapy with anthracycline, resulting in a clear recovery of systolic function of the left ventricle, as seen in the following echocardiogram.
2015
Chiodi, Elisabetta; Cannizzaro, Maria Teresa; Natali, Marcello; Ferrante, Zairo; Malta, Bruna; Montalto, Clorinda; Giganti, Melchiore; Benea, Giorgio...espandi
File in questo prodotto:
Non ci sono file associati a questo prodotto.

I documenti in SFERA sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/11392/2338715
 Attenzione

Attenzione! I dati visualizzati non sono stati sottoposti a validazione da parte dell'ateneo

Citazioni
  • ???jsp.display-item.citation.pmc??? ND
  • Scopus 1
  • ???jsp.display-item.citation.isi??? ND
social impact